SCHEMBL3889673

SCHEMBL3889673

CC(Cc1ccccn1)N1C(=O)c2ccccc2C1C(=O)NCc1cccc(OC(F)(F)F)c1

nearest known ligand 0.84

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 20/20 0.84
KCNH2 Q12809 15/20 0.84
SCN5A Q14524 15/20 0.84
KCNQ2 O43526 1/20 0.58
KCNA5 P22460 1/20 0.58
SCN2A Q99250 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3891906 0.91 SCN9A (1.00) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL3891943 0.84 SCN9A (0.80) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL3963578 0.83 SCN9A (0.72) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL3959385 0.83 SCN9A (0.72) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL3888980 0.83 SCN9A (1.00) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL3903558 0.83 SCN9A (0.81) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL13579017 0.82 SCN9A (0.68) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL3890328 0.82 SCN9A (0.80) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL3889685 0.81 SCN9A (0.71) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL3954655 0.81 SCN9A (0.76) SCN9AKCNH2SCN5AKCNQ2KCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009145718-A1 ISOINDOLINE DERIVATIVES COMPRISING AN ADDITIONAL HETEROCYCLIC GROUP AND THEIR USE IN THE TREATMENT OF PAIN DISORDERS ASTRAZENECA AB (SE) 2009-12-03 WO claimed
WO-2009145718-A1 ISOINDOLINE DERIVATIVES COMPRISING AN ADDITIONAL HETEROCYCLIC GROUP AND THEIR USE IN THE TREATMENT OF PAIN DISORDERS ASTRAZENECA AB (SE) 2009-12-03 WO disclosed
WO-2009145718-A1 ISOINDOLINE DERIVATIVES COMPRISING AN ADDITIONAL HETEROCYCLIC GROUP AND THEIR USE IN THE TREATMENT OF PAIN DISORDERS ASTRAZENECA AB (SE) 2009-12-03 WO disclosed